reversible ATX inhibitor w/ alt. binding mode
in vivo PD observed on oral dosing
from HTS screen and opt.
Bioorg. Med. Chem. Lett., Nov. 4, 2020
Novartis, Horsham, UK / Basel, CH
“compound 15a”
1 min read
“compound 15a” (Novartis reversible in vivo ATX inhibitor)
Search By Structure
- LY3502970
- S64315
- daridorexant
- “peptide 78”
- BMS-986144
- MLT-985
- EB-42486
- “compound 4d”
- “compound 60b”
- “compound 15a”
- “compound 31”
- “compound 36”
- BCPyr
- “compound 4j”
Molecules of the Month
2023
2022
2021
2020